AnPac Bio-Medical Science (ANPC) Reports Record Q1 for Paid CDA-Based Cancer Testing Volume in 2021

Go back to AnPac Bio-Medical Science (ANPC) Reports Record Q1 for Paid CDA-Based Cancer Testing Volume in 2021
(NASDAQ: ANPC) Delayed: 4.45 -0.01 (0.22%)
Previous Close $4.46    52 Week High
Open $4.45    52 Week Low
Day High $4.52    P/E N/A 
Day Low $4.43    EPS
Volume 24,263